It is a healthcare private limited company based in Jaipur, Rajasthan, India, established in 2021.
2021 | Jaipur, Rajasthan, India | ActiveJindal Life Science Private Limited, a active private limited company, was established on 27 August 2021 in Jaipur, Rajasthan, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U73200RJ2021PTC076674. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Its leadership includes Vinit Singh (Director), Lokesh Jindal (Director), Surabhi Jindal (Director). Past directors included Kapil Jindal, Shobha Jindal. It holds ₹5.95 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 201, Gurukripa Towers, C-43, Mahaveer Marg, C-Scheme, Jaipur, Rajasthan, 302001.
U73200RJ2021PTC076674
076674
27 August 2021
₹2.00 Cr
₹2.00 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Jindal Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinit Singh | Director | 06 Feb 2023 | Current |
| Lokesh Jindal | Director | 27 Aug 2021 | Current |
| Surabhi Jindal | Director | 27 Aug 2021 | Current |
| Anu Agrawal | Director | 14 Feb 2023 | Current |
| Sandeep | Director | 06 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2023 | Past |
| Pramod Abcsdd | Director | 16 Jan 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jindal Life Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 30507.3% decrease in profit. The company's net worth Soared by an impressive increase of 6210.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Jindal Life Science had a public holding of 63.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹59,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2024 | Others | ₹1.00 Cr | Open |
| 01 Mar 2023 | Others | ₹4.95 Cr | Open |
Explore comprehensive loan charge details -
Jindal Life Science has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jindal Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Jindal Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100938473 was registered on 10 Jun 2024. was completed.
The activity Jindal Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
A charge with Others amounted to Rs. 4.95 Cr with Charge ID 100705555 was registered on 01 Mar 2023. was recorded as a recent event.
Progress on Anu Agrawal was appointed as a Director was appointed as a Director on 14 Feb 2023 & has been associated with this company since 2 years 10 months . was documented.
Vinit Singh was appointed as a Director was appointed as a Director on 06 Feb 2023 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
The CIN of Jindal Life Science Private Limited is U73200RJ2021PTC076674.
Jindal Life Science Private Limited is headquartered at 201, Gurukripa Towers, C-43, Mahaveer Marg, C-Scheme, Jaipur, Rajasthan, 302001.
Jindal Life Science Private Limited was incorporated on 27 August 2021.
The current directors of Jindal Life Science Private Limited are
The primary industry of Jindal Life Science Private Limited is Healthcare.
Jindal Life Science Private Limited is unlisted.
The authorized capital of Jindal Life Science Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Jindal Life Science Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX